226 related articles for article (PubMed ID: 27633889)
41. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528
[TBL] [Abstract][Full Text] [Related]
42. Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.
Adhikari UK; Tayebi M; Rahman MM
J Immunol Res; 2018; 2018():6718083. PubMed ID: 30402510
[TBL] [Abstract][Full Text] [Related]
43. Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.
del Guercio MF; Alexander J; Kubo RT; Arrhenius T; Maewal A; Appella E; Hoffman SL; Jones T; Valmori D; Sakaguchi K; Grey HM; Sette A
Vaccine; 1997 Mar; 15(4):441-8. PubMed ID: 9141216
[TBL] [Abstract][Full Text] [Related]
44. Contriving multiepitope subunit vaccine by exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated malignancy.
Ojha R; Nandani R; Prajapati VK
J Cell Physiol; 2019 May; 234(5):6437-6448. PubMed ID: 30362500
[TBL] [Abstract][Full Text] [Related]
45. Exploratory algorithm to devise multi-epitope subunit vaccine by investigating Leishmania donovani membrane proteins.
Khatoon N; Pandey RK; Ojha R; Aathmanathan VS; Krishnan M; Prajapati VK
J Biomol Struct Dyn; 2019 Jun; 37(9):2381-2393. PubMed ID: 30047323
[TBL] [Abstract][Full Text] [Related]
46. Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.
Kumai T; Lee S; Cho HI; Sultan H; Kobayashi H; Harabuchi Y; Celis E
Cancer Immunol Res; 2017 Jan; 5(1):72-83. PubMed ID: 27941004
[TBL] [Abstract][Full Text] [Related]
47. Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches.
Nezafat N; Eslami M; Negahdaripour M; Rahbar MR; Ghasemi Y
Mol Biosyst; 2017 Mar; 13(4):699-713. PubMed ID: 28194462
[TBL] [Abstract][Full Text] [Related]
48. Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study.
Nosrati M; Hajizade A; Nazarian S; Amani J; Namvar Vansofla A; Tarverdizadeh Y
Mol Immunol; 2019 Dec; 116():106-116. PubMed ID: 31634814
[TBL] [Abstract][Full Text] [Related]
49. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
[TBL] [Abstract][Full Text] [Related]
50. Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity.
Chen C; Li J; Bi Y; Yang L; Meng S; Zhou Y; Jia X; Meng S; Sun L; Liu W
Vaccine; 2013 Apr; 31(14):1838-47. PubMed ID: 23395588
[TBL] [Abstract][Full Text] [Related]
51. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.
Rosendahl Huber SK; Camps MG; Jacobi RH; Mouthaan J; van Dijken H; van Beek J; Ossendorp F; de Jonge J
PLoS One; 2015; 10(6):e0127969. PubMed ID: 26046664
[TBL] [Abstract][Full Text] [Related]
52. Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses.
Lu J; Higashimoto Y; Appella E; Celis E
J Immunol; 2004 Apr; 172(7):4575-82. PubMed ID: 15034075
[TBL] [Abstract][Full Text] [Related]
53. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
[TBL] [Abstract][Full Text] [Related]
54. An immunoinformatics approach to design a multi-epitope vaccine against Mycobacterium tuberculosis exploiting secreted exosome proteins.
Sharma R; Rajput VS; Jamal S; Grover A; Grover S
Sci Rep; 2021 Jul; 11(1):13836. PubMed ID: 34226593
[TBL] [Abstract][Full Text] [Related]
55. Novel in silico tools for designing peptide-based subunit vaccines and immunotherapeutics.
Dhanda SK; Usmani SS; Agrawal P; Nagpal G; Gautam A; Raghava GPS
Brief Bioinform; 2017 May; 18(3):467-478. PubMed ID: 27016393
[TBL] [Abstract][Full Text] [Related]
56. An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant.
Nazarian S; Mousavi Gargari SL; Rasooli I; Amani J; Bagheri S; Alerasool M
J Microbiol Methods; 2012 Jul; 90(1):36-45. PubMed ID: 22525194
[TBL] [Abstract][Full Text] [Related]
57. Formulation and characterization of a ten-peptide single-vial vaccine, EP-2101, designed to induce cytotoxic T-lymphocyte responses for cancer immunotherapy.
Beebe M; Qin M; Moi M; Wu S; Heiati H; Walker L; Newman M; Fikes J; Ishioka GY
Hum Vaccin; 2008; 4(3):210-8. PubMed ID: 18382135
[TBL] [Abstract][Full Text] [Related]
58. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
Dewi SK; Ali S; Prasasty VD
Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
[TBL] [Abstract][Full Text] [Related]
59. The optimization of helper T lymphocyte (HTL) function in vaccine development.
Alexander J; Fikes J; Hoffman S; Franke E; Sacci J; Appella E; Chisari FV; Guidotti LG; Chesnut RW; Livingston B; Sette A
Immunol Res; 1998; 18(2):79-92. PubMed ID: 9844827
[TBL] [Abstract][Full Text] [Related]
60. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
